June 29 (Reuters) - ADVENTRX Pharmaceuticals Inc:
* Announces financing
* Says to sell its 5% series B convertible preferred stock to a single
institutional investor
* Says gross proceeds of sale is about $1.36 million
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Announces financing
* Says to sell its 5% series B convertible preferred stock to a single
institutional investor
* Says gross proceeds of sale is about $1.36 million
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2009 AFX News
